321 related articles for article (PubMed ID: 30206764)
1. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
[TBL] [Abstract][Full Text] [Related]
2. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
5. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.
Amsbaugh MJ; Mahajan A; Thall PF; McAleer MF; Paulino AC; Grosshans D; Khatua S; Ketonen L; Fontanilla H; McGovern SL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):144-148. PubMed ID: 30610915
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma.
Fleischmann DF; Jenn J; Corradini S; Ruf V; Herms J; Forbrig R; Unterrainer M; Thon N; Kreth FW; Belka C; Niyazi M
Radiother Oncol; 2019 Sep; 138():99-105. PubMed ID: 31252301
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
Lu VM; Welby JP; Mahajan A; Laack NN; Daniels DJ
Childs Nerv Syst; 2019 May; 35(5):739-746. PubMed ID: 30879125
[TBL] [Abstract][Full Text] [Related]
8. Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity.
Marwah R; Xing D; Squire T; Soon YY; Gan HK; Ng SP
J Neurooncol; 2023 Sep; 164(3):505-524. PubMed ID: 37733174
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E
Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515
[TBL] [Abstract][Full Text] [Related]
10. PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma.
Kurz SC; Cabrera LP; Hastie D; Huang R; Unadkat P; Rinne M; Nayak L; Lee EQ; Reardon DA; Wen PY
Neurology; 2018 Oct; 91(14):e1355-e1359. PubMed ID: 30171077
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
Fried I; Lossos A; Ben Ami T; Dvir R; Toledano H; Ben Arush MW; Postovski S; Abu Kuidar A; Yalon M; Weintraub M; Benifla M
J Neurooncol; 2018 Jan; 136(1):189-195. PubMed ID: 29143272
[TBL] [Abstract][Full Text] [Related]
12. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
[TBL] [Abstract][Full Text] [Related]
13. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
Zamora PL; Miller SR; Kovoor JJ
Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
Tong E; Horsley P; Wheeler H; Wong M; Venkatesha V; Chan J; Kastelan M; Back M
J Neurooncol; 2024 May; 168(1):69-76. PubMed ID: 38551747
[TBL] [Abstract][Full Text] [Related]
15. Palliative reirradiation for progressive diffuse intrinsic pontine glioma.
Fontanilla HP; Pinnix CC; Ketonen LM; Woo SY; Vats TS; Rytting ME; Wolff JE; Mahajan A
Am J Clin Oncol; 2012 Feb; 35(1):51-7. PubMed ID: 21297433
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.
Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I
Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887
[TBL] [Abstract][Full Text] [Related]
17. Second re-irradiation for DIPG progression, re-considering "old strategies" with new approaches.
Morales La Madrid A; Santa-María V; Cruz Martinez O; Mora J; Puerta Roldan P; Guillen Quesada A; Suñol Capella M; de Torres Gomez-Pallete C; Lassaletta A; Laperriere N; Villà S; Bouffet E
Childs Nerv Syst; 2017 May; 33(5):849-852. PubMed ID: 28251325
[TBL] [Abstract][Full Text] [Related]
18. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
[TBL] [Abstract][Full Text] [Related]
19. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
